查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513622

下一代输液帮浦市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2033

Next Generation IV Infusion Pumps Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 350 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了关于下一代输液帮浦全球市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

关键见解

  • 下一代输液帮浦市场规模（2024 年）：31 亿美元
  • 预计市值（2033 年）：58 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：7.2%

下一代输液帮浦市场：调查范围

下一代输液帮浦对于将药物、液体和营养物质直接准确地输送到患者的血液中至关重要。这些先进的泵浦融合了无线连接、电子健康记录 (EHR) 整合和智慧警报系统等功能，以提高安全性和效率。市场提供多种帮浦类型，包括高容量帮浦、注射帮浦和用于医院、门诊诊所、家庭保健机构和门诊手术中心的门诊帮浦。

推动市场成长的因素：

下一代输液帮浦的全球市场受到几个关键因素的推动，例如慢性病盛行率的增加推动了对先进输液治疗的需求。人口老化的加剧和医院获得性感染（HAI）发病率的上升进一步推动了市场的扩张。技术进步，例如具有增强安全功能的智慧输液帮浦的市场开发，将透过提高治疗准确性和患者治疗效果来推动市场成长。此外，向家庭医疗保健和门诊护理的转变正在推动便携式、易于使用的输液设备的采用。

市场限制因素：

儘管成长前景广阔，但下一代输液帮浦市场面临监管合规性、高设备成本和技术故障风险等课题。有关输液帮浦的製造、销售和使用的严格法规给製造商带来了合规负担，影响了市场进入障碍和营运成本。此外，先进输液系统的高成本以及对潜在设备故障和错误的担忧给市场渗透带来了课题，特别是在资源有限的环境中。解决这些监管和经济障碍需要行业利益相关者和政策制定者之间的合作，以确保获得安全且负担得起的输液解决方案。

市场机会：

由于技术创新、改善的医疗基础设施和不断发展的病患照护模式，下一代输液帮浦市场提供了巨大的成长机会。远端监控和远距医疗平台等数位健康技术的集成，增加了患者接受输液治疗的机会，并提高了治疗依从性和结果。此外，输液帮浦在传统医疗保健环境之外的使用越来越多，例如紧急医疗服务和军事医学，正在扩大市场范围。战略合作伙伴关係、研发投资以及推出经济高效且易于使用的输液解决方案对于利用新的商机并在动态的医疗保健领域保持市场领先地位至关重要。

本报告解决的关键问题

  • 推动下一代输液帮浦市场全球成长的关键因素是什么？
  • 哪些类型的帮浦和应用正在推动输液帮浦在各种医疗保健环境中的采用？
  • 由于技术进步，下一代输液帮浦市场的竞争格局将会发生怎样的变化？
  • 谁是下一代输液帮浦市场的主要参与者？ 他们采取了哪些策略来维持市场地位？
  • 全球新一代输液帮浦市场的新趋势与未来前景如何？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含/排除

第三章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章关键成功因素

  • 主要品牌占有率/已安装设备的偏好
  • 新产品发布
  • 监管场景
  • 报销情况
  • 杵分析
  • 波特的分析
  • 价值链分析
  • 主要促销策略：依製造商分类

第五章市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第 6 章 COVID-19 危机分析

  • 新冠肺炎 (COVID-19) 与影响分析
    • 收入：依泵浦类型划分
    • 收入：依用途分类
    • 收入：依最终用户分类
    • 依地区划分的收入
  • 2024 年市场情景

第七章全球新一代输液帮浦市场需求分析

  • 2019-2023 年过去的市场销售（单位）分析
  • 2024-2033 年当前及未来市场销售（单位）预测
    • 年成长趋势分析

第 8 章全球新一代输液帮浦市场 - 价格分析

  • 区域价格分析：依泵浦类型
  • 价格明细
    • 製造商级别
    • 经销商级
  • 世界平均价格分析基准
  • 定价假设

第九章全球新一代输液帮浦市场需求分析（金额或规模，十亿美元）

  • 2019-2023 年历史市值分析（十亿美元）
  • 2024-2033 年当前及未来市场价值（十亿美元）预测
    • 年成长趋势分析
    • 绝对数量机会分析

第 10 章全球新一代输液帮浦市场分析：依帮浦类型

  • 简介/主要发现
  • 2019-2023 年依泵浦类型划分的历史市场规模（十亿美元）和销售量（单位）分析
  • 2024-2033 年依泵浦类型划分的当前和未来市场规模（十亿美元）和销售（台）分析和预测
    • 大容量输液系统
    • 注射器注射系统
    • 电子携带式输液系统
    • 病人自我镇痛泵
    • 一次性弹性体输液系统
    • 植入式输液系统
    • MRI 相容静脉输液系统
    • 抛弃式静脉注射
  • 市场吸引力分析：依泵类型

第 11 章全球新一代输液帮浦市场分析：依应用

  • 简介/主要发现
  • 2019-2023 年依应用划分的历史市场规模（十亿美元）分析
  • 2024-2033 年当前和未来市场规模（依应用划分）的分析和预测（十亿美元）
    • 临床营养
    • 疼痛管理
    • 化疗
    • 抗生素管理
    • 其他
  • 市场吸引力分析：依应用分类

第 12 章全球新一代输液帮浦市场分析：依最终使用者划分

  • 简介/主要发现
  • 2019-2023 年最终用户历史市场规模（十亿美元）分析
  • 2024-2033 年最终用户当前和未来市场规模（十亿美元）的分析和预测
    • 医院
    • 门诊手术中心
    • 居家照护环境
    • 诊断中心
    • 其他
  • 市场吸引力分析：依最终用户分类

第 13 章全球下一代输液帮浦市场分析：依地区

  • 简介
  • 2019-2023 年依地区历史市场规模（十亿美元）及交易量（单位）分析
  • 2024-2033 年依地区划分的当前和未来市场规模（十亿美元）和销售（单位）分析和预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：依地区划分

第14章北美新一代输液帮浦市场分析

第十五章拉丁美洲下一代输液帮浦市场分析

第十六章欧洲新一代输液帮浦市场分析

第十七章南亚新一代输液帮浦市场分析

第十八章东亚地区新一代输液帮浦市场分析

第十九章大洋洲新一代输液帮浦市场分析

第 20 章中东和非洲 (MEA) 新一代输液帮浦市场分析

第21章市场结构分析

  • 市场分析：依公司层级
  • 主要公司市占率分析
  • 市场集中度
  • 市场现况分析

第22章竞争分析

  • 竞争对手仪表板
  • 竞争基准
  • 衝突详情
    • Gamastech SRL
    • Ambu A/S
    • Summit Medical Products, Inc.
    • Nipro Corporation
    • Terumo Corporation
    • Medtronic Plc.
    • Zyno Medical
    • Baxter International Inc.
    • Fresenius Kabi AG
    • B. Braun Melsungen AG
    • Becton, Dickinson Company（CareFusion）
    • Smiths Medical（Smiths Group plc.）
    • Hospira Inc.
    • iRadimed Corporation
    • vTitan

第 23 章先决条件与使用的缩写

第24章研究方法

简介目录
Product Code: PMRREP15781

Persistence Market Research has recently released a comprehensive report on the worldwide market for next generation IV infusion pumps. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Next Generation IV Infusion Pumps Market Size (2024E): USD 3.1 Billion
  • Projected Market Value (2033F): USD 5.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.2%

Next Generation IV Infusion Pumps Market - Report Scope:

Next generation IV infusion pumps are essential for the precise delivery of medications, fluids, and nutrients directly into a patient's bloodstream. These advanced pumps incorporate features such as wireless connectivity, integration with electronic health records (EHRs), and smart alarm systems to enhance safety and efficiency. The market serves hospitals, outpatient clinics, homecare settings, and ambulatory surgical centers, offering a variety of pump types, including large volume pumps, syringe pumps, and ambulatory pumps.

Market Growth Drivers:

The global next generation IV infusion pumps market is propelled by several key factors, including the increasing prevalence of chronic diseases, which drives the demand for advanced infusion therapy. The growing aging population and rising incidence of hospital-acquired infections (HAIs) further fuel market expansion. Technological advancements, such as the development of smart infusion pumps with enhanced safety features, promote market growth by improving treatment accuracy and patient outcomes. Additionally, the shift towards home-based healthcare and outpatient care supports the adoption of portable and user-friendly infusion devices.

Market Restraints:

Despite promising growth prospects, the next generation IV infusion pumps market faces challenges related to regulatory compliance, high device costs, and the risk of technical malfunctions. Stringent regulations governing the manufacturing, marketing, and use of infusion pumps impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, the high cost of advanced infusion systems and concerns about potential device failures or errors pose challenges for market penetration, particularly in resource-constrained settings. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to ensure access to safe and affordable infusion solutions.

Market Opportunities:

The next generation IV infusion pumps market presents significant growth opportunities driven by technological innovations, healthcare infrastructure improvements, and evolving patient care models. The integration of digital health technologies, such as remote monitoring and telehealth platforms, enhances patient access to infusion therapy and improves treatment adherence and outcomes. Additionally, the expanding application of infusion pumps beyond traditional healthcare settings, including in emergency medical services and military medicine, broadens the market scope. Strategic partnerships, investment in research and development, and the introduction of cost-effective and user-friendly infusion solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic healthcare landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the next generation IV infusion pumps market globally?
  • Which pump types and applications are driving infusion pump adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the next generation IV infusion pumps market?
  • Who are the key players contributing to the next generation IV infusion pumps market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global next generation IV infusion pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global next generation IV infusion pumps market, including Baxter International Inc., B. Braun Melsungen AG, and ICU Medical, Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced infusion solutions, including wireless-enabled pumps, integration with hospital information systems, and portable infusion devices, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving infusion therapy landscape.

Key Companies Profiled:

  • Gamastech S.R.L
  • Ambu A/S
  • Summit Medical Products, Inc.
  • Nipro Corporation
  • Terumo Corporation
  • Medtronic Plc.
  • Zyno Medical
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Becton, Dickinson Company (CareFusion)
  • Smith's Medical (Smiths Group plc.)
  • Hospira Inc.
  • iRadimed Corporation
  • vTitan

Key Segments Covered in Next-Generation IV Infusion Pumps Industry Research

Type of Pumps:

  • Large Volumetric Infusion Systems
  • Syringe Infusion Systems
  • Electronic-Ambulatory Infusion Systems
  • Patient Controlled Analgesia Pumps
  • Disposable Elastomeric Infusion Systems
  • Implantable Infusion Systems
  • MRI-Compatible IV Infusion Systems
  • IV Disposables

Application:

  • Clinical Nutrition
  • Pain Management
  • Chemotherapy
  • Antibiotic Management

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Diagnostic Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Brand Share/Preference of Equipment Installed
  • 4.2. New Product Launches
  • 4.3. Regulatory Scenario
  • 4.4. Reimbursement Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis
  • 4.8. Key Promotional Strategies by Manufacturers

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Injectable Drug Delivery Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Technological Advancements in Next Generation IV Infusion Pumps
    • 5.2.3. New Product Launches
    • 5.2.4. Cost of Products
    • 5.2.5. Rising Cardiac Diseases
    • 5.2.6. Growing Adoption Rate
    • 5.2.7. Strategic Mergers and Acquisitions Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Type of Pumps
    • 6.1.2. Revenue By Application
    • 6.1.3. Revenue By End User
    • 6.1.4. Revenue By Region
  • 6.2. 2024 Market Scenario

7. Global Next Generation IV Infusion Pumps Market Demand Volume Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Next Generation IV Infusion Pumps Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By-Type of Pumps
  • 8.2. Pricing Break Up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Next Generation IV Infusion Pumps Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Pumps

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Type of Pumps, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Type of Pumps, 2024-2033
    • 10.3.1. Large Volumetric Infusion Systems
    • 10.3.2. Syringe Infusion Systems
    • 10.3.3. Electronic-Ambulatory Infusion Systems
    • 10.3.4. Patient Controlled Analgesia Pumps
    • 10.3.5. Disposable Elastomeric Infusion Systems
    • 10.3.6. Implantable Infusion Systems
    • 10.3.7. MRI-Compatible IV Infusion Systems
    • 10.3.8. IV Disposables
  • 10.4. Market Attractiveness Analysis By Type of Pumps

11. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 11.3.1. Clinical Nutrition
    • 11.3.2. Pain Management
    • 11.3.3. Chemotherapy
    • 11.3.4. Antibiotic Management
    • 11.3.5. Others
  • 11.4. Market Attractiveness Analysis By Application

12. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Homecare Settings
    • 12.3.4. Diagnostic Centers
    • 12.3.5. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Type of Pumps
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Type of Pumps
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Market Trends
  • 14.9. Country Level Analysis & Forecast
    • 14.9.1. U.S. Next Generation IV Infusion Pumps Market
      • 14.9.1.1. Introduction
      • 14.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.9.1.2.1. By Type of Pumps
        • 14.9.1.2.2. By Application
        • 14.9.1.2.3. By End User
    • 14.9.2. Canada Next Generation IV Infusion Pumps Market
      • 14.9.2.1. Introduction
      • 14.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.9.2.2.1. By Type of Pumps
        • 14.9.2.2.2. By Application
        • 14.9.2.2.3. By End User

15. Latin America Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Argentina
      • 15.4.1.4. Rest of Latin America
    • 15.4.2. By Type of Pumps
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Type of Pumps
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Market Trends
  • 15.9. Country Level Analysis & Forecast
    • 15.9.1. Brazil Next Generation IV Infusion Pumps Market
      • 15.9.1.1. Introduction
      • 15.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.1.2.1. By Type of Pumps
        • 15.9.1.2.2. By Application
        • 15.9.1.2.3. By End User
    • 15.9.2. Argentina Next Generation IV Infusion Pumps Market
      • 15.9.2.1. Introduction
      • 15.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.2.2.1. By Type of Pumps
        • 15.9.2.2.2. By Application
        • 15.9.2.2.3. By End User
    • 15.9.3. Mexico Next Generation IV Infusion Pumps Market
      • 15.9.3.1. Introduction
      • 15.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.3.2.1. By Type of Pumps
        • 15.9.3.2.2. By Application
        • 15.9.3.2.3. By End User

16. Europe Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. BENELUX
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Type of Pumps
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Type of Pumps
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Market Trends
  • 16.9. Country Level Analysis & Forecast
    • 16.9.1. Germany Next Generation IV Infusion Pumps Market
      • 16.9.1.1. Introduction
      • 16.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.1.2.1. By Type of Pumps
        • 16.9.1.2.2. By Application
        • 16.9.1.2.3. By End User
    • 16.9.2. France Next Generation IV Infusion Pumps Market
      • 16.9.2.1. Introduction
      • 16.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.2.2.1. By Type of Pumps
        • 16.9.2.2.2. By Application
        • 16.9.2.2.3. By End User
    • 16.9.3. Italy Next Generation IV Infusion Pumps Market
      • 16.9.3.1. Introduction
      • 16.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.3.2.1. By Type of Pumps
        • 16.9.3.2.2. By Application
        • 16.9.3.2.3. By End User
    • 16.9.4. Spain Next Generation IV Infusion Pumps Market
      • 16.9.4.1. Introduction
      • 16.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.4.2.1. By Type of Pumps
        • 16.9.4.2.2. By Application
        • 16.9.4.2.3. By End User
    • 16.9.5. U.K. Next Generation IV Infusion Pumps Market
      • 16.9.5.1. Introduction
      • 16.9.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.5.2.1. By Type of Pumps
        • 16.9.5.2.2. By Application
        • 16.9.5.2.3. By End User
    • 16.9.6. BENELUX Next Generation IV Infusion Pumps Market
      • 16.9.6.1. Introduction
      • 16.9.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.6.2.1. By Type of Pumps
        • 16.9.6.2.2. By Application
        • 16.9.6.2.3. By End User
    • 16.9.7. Russia Next Generation IV Infusion Pumps Market
      • 16.9.7.1. Introduction
      • 16.9.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.7.2.1. By Type of Pumps
        • 16.9.7.2.2. By Application
        • 16.9.7.2.3. By End User

17. South Asia Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. Thailand
      • 17.4.1.3. Indonesia
      • 17.4.1.4. Malaysia
      • 17.4.1.5. Rest of South Asia
    • 17.4.2. By Type of Pumps
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Type of Pumps
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Market Trends
  • 17.9. Country Level Analysis & Forecast
    • 17.9.1. India Next Generation IV Infusion Pumps Market
      • 17.9.1.1. Introduction
      • 17.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.1.2.1. By Type of Pumps
        • 17.9.1.2.2. By Application
        • 17.9.1.2.3. By End User
    • 17.9.2. Indonesia Next Generation IV Infusion Pumps Market
      • 17.9.2.1. Introduction
      • 17.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.2.2.1. By Type of Pumps
        • 17.9.2.2.2. By Application
        • 17.9.2.2.3. By End User
    • 17.9.3. Malaysia Next Generation IV Infusion Pumps Market
      • 17.9.3.1. Introduction
      • 17.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.3.2.1. By Type of Pumps
        • 17.9.3.2.2. By Application
        • 17.9.3.2.3. By End User
    • 17.9.4. Thailand Next Generation IV Infusion Pumps Market
      • 17.9.4.1. Introduction
      • 17.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.4.2.1. By Type of Pumps
        • 17.9.4.2.2. By Application
        • 17.9.4.2.3. By End User

18. East Asia Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Type of Pumps
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Type of Pumps
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Market Trends
  • 18.9. Country Level Analysis & Forecast
    • 18.9.1. China Next Generation IV Infusion Pumps Market
      • 18.9.1.1. Introduction
      • 18.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.1.2.1. By Type of Pumps
        • 18.9.1.2.2. By Application
        • 18.9.1.2.3. By End User
    • 18.9.2. Japan Next Generation IV Infusion Pumps Market
      • 18.9.2.1. Introduction
      • 18.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.2.2.1. By Type of Pumps
        • 18.9.2.2.2. By Application
        • 18.9.2.2.3. By End User
    • 18.9.3. South Korea Next Generation IV Infusion Pumps Market
      • 18.9.3.1. Introduction
      • 18.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.3.2.1. By Type of Pumps
        • 18.9.3.2.2. By Application
        • 18.9.3.2.3. By End User

19. Oceania Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Type of Pumps
    • 19.4.3. By Application
    • 19.4.4. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Type of Pumps
    • 19.5.3. By Application
    • 19.5.4. By End User
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Market Trends
  • 19.9. Country Level Analysis & Forecast
    • 19.9.1. Australia Next Generation IV Infusion Pumps Market
      • 19.9.1.1. Introduction
      • 19.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.9.1.2.1. By Type of Pumps
        • 19.9.1.2.2. By Application
        • 19.9.1.2.3. By End User
    • 19.9.2. New Zealand Next Generation IV Infusion Pumps Market
      • 19.9.2.1. Introduction
      • 19.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.9.2.2.1. By Type of Pumps
        • 19.9.2.2.2. By Application
        • 19.9.2.2.3. By End User

20. Middle East and Africa (MEA) Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. North Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Type of Pumps
    • 20.4.3. By Application
    • 20.4.4. By End User
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Type of Pumps
    • 20.5.3. By Application
    • 20.5.4. By End User
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Market Trends
  • 20.9. Country Level Analysis & Forecast
    • 20.9.1. GCC Countries Next Generation IV Infusion Pumps Market
      • 20.9.1.1. Introduction
      • 20.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.1.2.1. By Type of Pumps
        • 20.9.1.2.2. By Application
        • 20.9.1.2.3. By End User
    • 20.9.2. Turkey Next Generation IV Infusion Pumps Market
      • 20.9.2.1. Introduction
      • 20.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.2.2.1. By Type of Pumps
        • 20.9.2.2.2. By Application
        • 20.9.2.2.3. By End User
    • 20.9.3. North Africa Next Generation IV Infusion Pumps Market
      • 20.9.3.1. Introduction
      • 20.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.3.2.1. By Type of Pumps
        • 20.9.3.2.2. By Application
        • 20.9.3.2.3. By End User
    • 20.9.4. South Africa Next Generation IV Infusion Pumps Market
      • 20.9.4.1. Introduction
      • 20.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.4.2.1. By Type of Pumps
        • 20.9.4.2.2. By Application
        • 20.9.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. Regional Footprint Analysis
    • 21.4.2. Product Footprint Analysis
    • 21.4.3. Channel Footprint Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Gamastech S.R.L
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials
      • 22.3.1.4. SWOT Analysis
      • 22.3.1.5. Sales Footprint
      • 22.3.1.6. Strategy Overview
      • 22.3.1.7. Key Developments
        • 22.3.1.7.1. Marketing Strategies
        • 22.3.1.7.2. Product Strategies
        • 22.3.1.7.3. Channel Strategies
    • 22.3.2. Ambu A/S
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials
      • 22.3.2.4. SWOT Analysis
      • 22.3.2.5. Sales Footprint
      • 22.3.2.6. Strategy Overview
      • 22.3.2.7. Key Developments
        • 22.3.2.7.1. Marketing Strategies
        • 22.3.2.7.2. Product Strategies
        • 22.3.2.7.3. Channel Strategies
    • 22.3.3. Summit Medical Products, Inc.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials
      • 22.3.3.4. SWOT Analysis
      • 22.3.3.5. Sales Footprint
      • 22.3.3.6. Strategy Overview
      • 22.3.3.7. Key Developments
        • 22.3.3.7.1. Marketing Strategies
        • 22.3.3.7.2. Product Strategies
        • 22.3.3.7.3. Channel Strategies
    • 22.3.4. Nipro Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials
      • 22.3.4.4. SWOT Analysis
      • 22.3.4.5. Sales Footprint
      • 22.3.4.6. Strategy Overview
      • 22.3.4.7. Key Developments
        • 22.3.4.7.1. Marketing Strategies
        • 22.3.4.7.2. Product Strategies
        • 22.3.4.7.3. Channel Strategies
    • 22.3.5. Terumo Corporation
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials
      • 22.3.5.4. SWOT Analysis
      • 22.3.5.5. Sales Footprint
      • 22.3.5.6. Strategy Overview
      • 22.3.5.7. Key Developments
        • 22.3.5.7.1. Marketing Strategies
        • 22.3.5.7.2. Product Strategies
        • 22.3.5.7.3. Channel Strategies
    • 22.3.6. Medtronic Plc.
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials
      • 22.3.6.4. SWOT Analysis
      • 22.3.6.5. Sales Footprint
      • 22.3.6.6. Strategy Overview
      • 22.3.6.7. Key Developments
        • 22.3.6.7.1. Marketing Strategies
        • 22.3.6.7.2. Product Strategies
        • 22.3.6.7.3. Channel Strategies
    • 22.3.7. Zyno Medical
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials
      • 22.3.7.4. SWOT Analysis
      • 22.3.7.5. Sales Footprint
      • 22.3.7.6. Strategy Overview
      • 22.3.7.7. Key Developments
        • 22.3.7.7.1. Marketing Strategies
        • 22.3.7.7.2. Product Strategies
        • 22.3.7.7.3. Channel Strategies
    • 22.3.8. Baxter International Inc.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials
      • 22.3.8.4. SWOT Analysis
      • 22.3.8.5. Sales Footprint
      • 22.3.8.6. Strategy Overview
      • 22.3.8.7. Key Developments
        • 22.3.8.7.1. Marketing Strategies
        • 22.3.8.7.2. Product Strategies
        • 22.3.8.7.3. Channel Strategies
    • 22.3.9. Fresenius Kabi AG
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials
      • 22.3.9.4. SWOT Analysis
      • 22.3.9.5. Sales Footprint
      • 22.3.9.6. Strategy Overview
      • 22.3.9.7. Key Developments
        • 22.3.9.7.1. Marketing Strategies
        • 22.3.9.7.2. Product Strategies
        • 22.3.9.7.3. Channel Strategies
    • 22.3.10. B. Braun Melsungen AG
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials
      • 22.3.10.4. SWOT Analysis
      • 22.3.10.5. Sales Footprint
      • 22.3.10.6. Strategy Overview
      • 22.3.10.7. Key Developments
        • 22.3.10.7.1. Marketing Strategies
        • 22.3.10.7.2. Product Strategies
        • 22.3.10.7.3. Channel Strategies
    • 22.3.11. Becton, Dickinson Company (CareFusion)
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials
      • 22.3.11.4. SWOT Analysis
      • 22.3.11.5. Sales Footprint
      • 22.3.11.6. Strategy Overview
      • 22.3.11.7. Key Developments
        • 22.3.11.7.1. Marketing Strategies
        • 22.3.11.7.2. Product Strategies
        • 22.3.11.7.3. Channel Strategies
    • 22.3.12. Smiths Medical (Smiths Group plc.)
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials
      • 22.3.12.4. SWOT Analysis
      • 22.3.12.5. Sales Footprint
      • 22.3.12.6. Strategy Overview
      • 22.3.12.7. Key Developments
        • 22.3.12.7.1. Marketing Strategies
        • 22.3.12.7.2. Product Strategies
        • 22.3.12.7.3. Channel Strategies
    • 22.3.13. Hospira Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials
      • 22.3.13.4. SWOT Analysis
      • 22.3.13.5. Sales Footprint
      • 22.3.13.6. Strategy Overview
      • 22.3.13.7. Key Developments
        • 22.3.13.7.1. Marketing Strategies
        • 22.3.13.7.2. Product Strategies
        • 22.3.13.7.3. Channel Strategies
    • 22.3.14. iRadimed Corporation
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials
      • 22.3.14.4. SWOT Analysis
      • 22.3.14.5. Sales Footprint
      • 22.3.14.6. Strategy Overview
      • 22.3.14.7. Key Developments
        • 22.3.14.7.1. Marketing Strategies
        • 22.3.14.7.2. Product Strategies
        • 22.3.14.7.3. Channel Strategies
    • 22.3.15. vTitan
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials
      • 22.3.15.4. SWOT Analysis
      • 22.3.15.5. Sales Footprint
      • 22.3.15.6. Strategy Overview
      • 22.3.15.7. Key Developments
        • 22.3.15.7.1. Marketing Strategies
        • 22.3.15.7.2. Product Strategies
        • 22.3.15.7.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology